FDA Drug Recalls

Recalls / Class II

Class IID-1295-2014

Product

INDOMETHACIN Capsules USP, 50 mg, a) 100 count bottle, (NDC 0093-4030-01), b) 500 count bottle, (NDC 0093-4030-05), Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960

Affected lot / code info
TE38139, Exp. 08/16, TE39022, Exp. 09/16,

Why it was recalled

CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements.

Recalling firm

Firm
Teva Pharmaceuticals USA
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
425 Privet Rd, Horsham, Pennsylvania 19044-1220

Distribution

Quantity
5812 bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2014-03-24
FDA classified
2014-05-12
Posted by FDA
2014-05-21
Terminated
2014-11-14
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1295-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls